These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10155675)

  • 41. Cost-effectiveness of Helicobacter pylori eradication therapy in duodenal ulcer disease.
    Jönsson B
    Scand J Gastroenterol Suppl; 1996; 215():90-5. PubMed ID: 8722390
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of omeprazole and histamine H2-receptor antagonists in the treatment of elderly and young patients with reflux oesophagitis.
    James OF; Parry-Billings KS
    Age Ageing; 1994 Mar; 23(2):121-6. PubMed ID: 8023719
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis.
    Cucchiara S; Minella R; Iervolino C; Franco MT; Campanozzi A; Franceschi M; D'Armiento F; Auricchio S
    Arch Dis Child; 1993 Dec; 69(6):655-9. PubMed ID: 8285777
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Economic analysis of alternative treatments for persistent gastro-oesophageal reflux disease.
    Hillman AL
    Scand J Gastroenterol Suppl; 1994; 201():98-102. PubMed ID: 8047833
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Omeprazole (20 mg daily) compared to ranitidine (150 mg twice daily) in the treatment of esophagitis caused by reflux. Results of a double-blind randomized multicenter trial in France and Belgium].
    Zeitoun P; Rampal P; Barbier P; Isal JP; Eriksson S; Carlsson R
    Gastroenterol Clin Biol; 1989 May; 13(5):457-62. PubMed ID: 2666237
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A randomized, prospective, comparative, multicenter study of rabeprazole and ranitidine in the treatment of reflux esophagitis].
    Jeong HY; Lee BS; Sung JK; Lee TY; Yoon SJ; Kim SJ; Chung IK; Lee SH; Shin JE; Lee DS; Baek JT; Nam SW; Yoon SJ; Kim SH; Lee GS; Lee JM; Kim AN; Oh JI
    Korean J Gastroenterol; 2006 Jan; 47(1):15-21. PubMed ID: 16434864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study.
    Sandmark S; Carlsson R; Fausa O; Lundell L
    Scand J Gastroenterol; 1988 Jun; 23(5):625-32. PubMed ID: 3041558
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Esomeprazole: a review of its use in the management of acid-related disorders in the US.
    Scott LJ; Dunn CJ; Mallarkey G; Sharpe M
    Drugs; 2002; 62(7):1091-118. PubMed ID: 11985491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost and quality effects of alternative treatments for persistent gastroesophageal reflux disease.
    Hillman AL; Bloom BS; Fendrick AM; Schwartz JS
    Arch Intern Med; 1992 Jul; 152(7):1467-72. PubMed ID: 1627026
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Meta-analysis of randomized controlled trials comparing standard clinical doses of omeprazole and lansoprazole in erosive oesophagitis.
    Sharma VK; Leontiadis GI; Howden CW
    Aliment Pharmacol Ther; 2001 Feb; 15(2):227-31. PubMed ID: 11148442
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ranitidine vs metoclopramide in the medical treatment of reflux esophagitis.
    Guslandi M; Testoni PA; Passaretti S; Masci E; Ballarin E; Comin U; Marchi R; Ronchi G; Tittobello A
    Hepatogastroenterology; 1983 Jun; 30(3):96-8. PubMed ID: 6309637
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Evaluation of the cost of maintenance therapy (6 months) with 150 mg ranitidine vs 20 mg omeprazole vs 20 mg omeprazole every other day in duodenal ulcer].
    Di Mario F; Grasso GA; Battaglia G; De Boni M; Vianello F; De Bona M; Pasquino M; Chiozzini G; Saggioro A
    Minerva Gastroenterol Dietol; 1993 Jun; 39(2):83-7. PubMed ID: 8364105
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lansoprazole. An update of its pharmacological properties and clinical efficacy in the management of acid-related disorders.
    Langtry HD; Wilde MI
    Drugs; 1997 Sep; 54(3):473-500. PubMed ID: 9279507
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole.
    Pace F; Annese V; Prada A; Zambelli A; Casalini S; Nardini P; Bianchi Porro G;
    Dig Liver Dis; 2005 Oct; 37(10):741-50. PubMed ID: 16024305
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reflux oesophagitis in heavy drinkers. Effect of ranitidine and alginate/metoclopramide.
    Tønnesen H; Andersen JR; Christoffersen P; Kaas-Claesson N
    Digestion; 1987; 38(2):69-73. PubMed ID: 3440508
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of oesophageal bile reflux in children: the results of a prospective study with omeprazole.
    Orel R; Brecelj J; Homan M; Heuschkel R
    J Pediatr Gastroenterol Nutr; 2006 Apr; 42(4):376-83. PubMed ID: 16641575
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The cost of long term therapy for gastro-oesophageal reflux disease: a randomised trial comparing omeprazole and open antireflux surgery.
    Myrvold HE; Lundell L; Miettinen P; Pedersen SA; Liedman B; Hatlebakk J; Julkunen R; Levander K; Lamm M; Mattson C; Carlsson J; Ståhlhammar NO;
    Gut; 2001 Oct; 49(4):488-94. PubMed ID: 11559644
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study.
    Veldhuyzen van Zanten SJ; Chiba N; Armstrong D; Barkun A; Thomson A; Smyth S; Escobedo S; Lee J; Sinclair P
    Am J Gastroenterol; 2005 Jul; 100(7):1477-88. PubMed ID: 15984968
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Triple therapy with ranitidine or lansoprazole in the treatment of Helicobacter pylori-associated duodenal ulcer.
    Lazzaroni M; Bargiggia S; Bianchi Porro G
    Am J Gastroenterol; 1997 Apr; 92(4):649-52. PubMed ID: 9128316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.